Found vs SnagRx: Pricing, meds, and program differences
Quick verdict: Found is built around a biology-first, personalized medically supervised program with insurance options and plans starting as low as $39, while SnagRx focuses on low, flat pricing for compounded semaglutide and tirzepatide from $69/$119 on a 12-month plan with named pharmacies and next-day shipping.
Explore Found plans starting at $39
Pricing model and commitments compared
Found advertises affordable monthly plans and a get-started price as low as $39 and states most insurance is accepted. Some branded GLP-1 pricing is advertised via insurance with 12 month commitments and Found membership prices vary (examples captured: $49/mo membership billed annually, $50/mo branded copay through Medicare programs). SnagRx advertises compounded semaglutide from $69/month and tirzepatide from $119/month on the 12-month plan, noting month-to-month rates are $99 and $149. SnagRx emphasizes price locked flat at every dose for the life of treatment on the annual plan.
How pricing commitments differ
Found highlights insurance acceptance for many patients and multiple pricing lines including membership and branded medication pathways, and lists offers tied to 12 month commitments in some advertisements. SnagRx requires a 12-month plan to get the $69/$119 figures and makes clear the no-commitment equivalents are higher month-to-month.
Medication types, compounding, and regulatory notes
Both providers offer compounded GLP-1s. Found lists compounded semaglutide and tirzepatide and notes certain medications are FDA-approved for conditions other than weight, and that compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy and may not be available in all states. SnagRx offers compounded semaglutide and tirzepatide and likewise states compounded medications are not FDA-approved and are not evaluated by FDA for safety, efficacy, or quality. SnagRx explicitly states it does not provide branded Ozempic, Wegovy, Mounjaro, or Zepbound on its compounded offers.
See Found medication and insurance options
Program model and clinical oversight
Found emphasizes a biology-first, personalized medically supervised weight loss program that targets hormones, metabolism, sleep, and behavior and includes coaching-style program elements in its descriptions. Found states Rx is subject to provider review and clinical eligibility. SnagRx centers on clinician-prescribed compounded GLP-1s delivered via a telehealth assessment and states OpenLoop Health clinicians will meet with individuals after checkout to determine prescription eligibility. SnagRx states the assessment does not create a doctor patient relationship and that clinician review typically occurs within five hours and always within 24.
Fulfillment, pharmacies, and logistics
SnagRx names its US 503A partner pharmacies, states next-day UPS or FedEx temperature controlled shipping and free shipping, and highlights clinician network and pharmacy partners covering 48 states. Found states it handles insurance paperwork and references Medicare GLP-1 Bridge Program details for eligible Part D members, with some branded medication copay examples such as as low as $50/mo through Medicare in captured copy. Found also notes compounded GLP-1s may not be available in all states.
Support and extras
Found advertises a holistic, whole-body approach and personalized plans with flexible pricing and cancel anytime language in captured bullets. SnagRx explicitly states no coaching or nutrition programming is provided and advertises no monthly membership and cancel anytime for its compounded plan purchases. SnagRx also presents a refund if a prescription is declined and a 6-month weight-loss guarantee with terms applied.
| Criteria | Found | SnagRx |
|---|---|---|
| Starting price | Get started for as low as $39; membership/pricing varies | From $69/mo semaglutide on 12-month plan ($99 mo-to-mo) |
| Pricing model | Affordable monthly plans; insurance accepted; membership options | 12-month plan price locked flat at every dose; month-to-month higher |
| Medications offered | Semaglutide, tirzepatide, branded and compounded pathways noted; Rx subject to review | Compounded semaglutide and tirzepatide only; no branded GLP-1s on compounding offers |
| Clinical model | Personalized, medically supervised biology-first program; provider review required | Telehealth assessment; OpenLoop Health clinician review; clinician network covers 48 states |
| Shipping and pharmacies | Handles insurance paperwork; availability varies by state | Named US 503A pharmacies; next-day temperature-controlled shipping; free shipping |
| Guarantees and refunds | Pricing and offers include discount conditions; policies vary | Full refund if prescription declined; 6-month weight-loss guarantee terms apply |
Explore SnagRx 12-month pricing
Which differences matter most
If insurance, brand-name medication pathways, and a program built around metabolic biology and coaching matter to you, Found documents insurance handling and a biology-first personalized program with start prices as low as $39. If predictable, locked-in compounded pricing across titration, named 503A pharmacies, next-day shipping, and a clinician network with fast review are your priorities, SnagRx documents $69/$119 12-month plan rates, price lock, and named partners.
Check SnagRx compounded plan details
Conclusion: Found vs SnagRx
Found vs SnagRx splits on program model and pricing approach. Found emphasizes personalized, medically supervised programs with insurance options and starting prices as low as $39. SnagRx emphasizes low annual-plan rates for compounded GLP-1s with a price lock, named pharmacies, and rapid clinician review from OpenLoop Health. Both note compounded GLP-1s are not FDA-approved finished products and Rx decisions are subject to clinician review and eligibility.
Choose Found if you want a biology-first, personalized medically supervised weight loss program with insurance options and flexible pricing starting as low as $39.
Choose SnagRx if you want predictable, locked-in compounded pricing across titration with named US 503A pharmacies, next-day shipping, and clinician review on a 12-month plan from $69/month semaglutide or $119/month tirzepatide.